Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC).

[1]  T. Welte,et al.  Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Christopher A. Jones,et al.  Robo4 is a vascular-specific receptor that inhibits endothelial migration. , 2003, Developmental biology.

[3]  D. Morton,et al.  SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. , 2003, Cancer research.

[4]  J. Minna,et al.  SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. , 2002, Cancer research.

[5]  Michael Gorn,et al.  Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. , 2002, Genomics.

[6]  Lukasz Huminiecki,et al.  In Silico Cloning of Novel Endothelial-Specific Genes , 2000 .

[7]  G. Gastl,et al.  Thrombocytes Are the Major Source for Soluble Vascular Endothelial Growth Factor in Peripheral Blood , 2000, Oncology.

[8]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[9]  M. Volm,et al.  Prognostic value of vascular endothelial growth factor and its receptor Flt‐1 in squamous cell lung cancer , 1997, International journal of cancer.

[10]  T. Sawada,et al.  Prognostic value of vascular endothelial growth factor expression in gastric carcinoma , 1996, Cancer.

[11]  M. Toi,et al.  Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast Cancer , 1994, Japanese journal of cancer research : Gann.

[12]  G. van Kaick,et al.  New aspects in the staging of lung cancer. Prospective validation of the international union against cancer TNM classification , 1992, Cancer.

[13]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[14]  S. Groshen,et al.  Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  D. Ettinger,et al.  Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  K. Eguchi,et al.  Prognostic factors in non-small cell lung cancer: multiregression analysis in the National Cancer Center Hospital (Japan) , 2004, Journal of Cancer Research and Clinical Oncology.

[17]  D. Parkin.  The global burden of cancer. , 1998, Seminars in cancer biology.